BioCryst Pharmaceuticals (BCRX) had the highest return in Q3 2013 by a US stock, returning 366.7%.

ASSET	QUARTER	% RETURN
BioCryst Pharmaceuticals (BCRX)	Q3 2013	366.67%
GT Biopharma (GTBP)	Q3 2013	326.92%
Quipt Home Medical (QIPT)	Q3 2013	272%
Armata Pharmaceuticals (ARMP)	Q3 2013	240%
Catalyst Pharmaceuticals (CPRX)	Q3 2013	235.16%
Scienture (SCNX)	Q3 2013	228.57%
Iovance Biotherapeutics (IOVA)	Q3 2013	227.5%
Rockwell Medical (RMTI)	Q3 2013	211.48%
Duos Technologies (DUOT)	Q3 2013	200%
Dolphin Entertainment (DLPN)	Q3 2013	200%
Daqo New Energy Corp ADR (DQ)	Q3 2013	187.61%
Arrowhead Pharmaceuticals (ARWR)	Q3 2013	180.3%
Xpel (XPEL)	Q3 2013	179.07%
InnovAge (INNV)	Q3 2013	164.71%
Sphere 3D (ANY)	Q3 2013	162.05%
Arcturus Therapeutics (ARCT)	Q3 2013	161.45%
Inovio Pharmaceuticals (INO)	Q3 2013	152.44%
Cosmos Health (COSM)	Q3 2013	152%
JinkoSolar (JKS)	Q3 2013	142.47%
Galectin Therapeutics (GALT)	Q3 2013	134.59%
Retractable Technologies (RVP)	Q3 2013	128.68%
NextTrip (NTRP)	Q3 2013	126.09%
OLB (OLB)	Q3 2013	125%
Supercom (SPCB)	Q3 2013	123.18%
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN)	Q3 2013	122.22%